Johnson & Johnson (JNJ)

Listed in the US · Manufacturing · Pharmaceutical preparations

$275.20

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $275.20 on 29 Oct 2026. The share price traded between $185.12 and $281.07 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close $275.20

Low $185.12High $281.07

Market cap$662.5Blast close × shares
P/E41.7on reported profit, last four quarters
Net profit$16,095Mlast 12 months
Return on equity32.9%year to Dec 2025
EBITDA margin43.6%year to Dec 2025
Debt to equity0.61year to Dec 2025
Net margin28.5%year to Dec 2025
Dividend yield1.91%last 12 months

Price trend

Revenue and profit

RevenueNet profit$ million
025,00050,00075,000100,000
YearJan 2022Jan 2023Dec 2023Dec 2024Dec 2025
Revenue78,74079,99085,15988,82194,193
Net profit20,87817,94135,15314,06626,804
EBITDA margin34.0%33.3%27.4%27.9%43.6%
Borrowings35,88241,19330,80138,38349,933

$ million. Over three years, compounded: revenue grew 5.6% a year, net profit grew 14.3% a year.

Recent filings

Questions about Johnson & Johnson

What is Johnson & Johnson's market value?

Johnson & Johnson's market value is $662.5B as of 29 Oct 2026 close: the last close times the shares in issue. Its P/E is 41.7, the last close over earnings per share for the last four reported quarters.

Go further with JNJ

Free to start: test a trading idea on JNJ's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceutical preparations), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.